Target optimistic about specialty pharmacy

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Audio Q&A: It has been estimated that specialty accounts for about 20% of the total drug spend, representing tremendous opportunities for industry players including Target. To learn more about the Target Specialty Pharmacy business and how it is helping support patients and manage rising specialty pharmacy costs, DSN senior editor Antoinette Alexander spoke with Kevin Ronneberg, associate medical director at Target.

Smartphone users can click here to listen.